Idenix Pharmaceuticals
In Seth Klarman's portfolio · Baupost Group
Ticker IDIX
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Baupost Group 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2014 | Sell | 0 | |
| Q2 2014 | No change | 53,331,109 | 20.7% |
| Q1 2014 | Add 44% | 53,331,109 | 7.3% |
| Q4 2013 | Add 24% | 36,910,868 | 6.3% |
| Q3 2013 | Add 11% | 29,665,693 | 4.4% |
| Q2 2013 | First 13F | 26,767,000 | 2.4% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.